Table 3 Pharmacotherapy of patients in HF stage C at discharge and at the study visit
Discharge | Study visit | p | |
|---|---|---|---|
Beta blocker, n (%) | 210 (93.3) | 191 (84.9) | 0.0021 |
ACEi/ARB, n (%) | 197 (87.6) | 187 (83.1) | 0.1541 |
MRA, n (%) | 30 (13.3) | 19 (8.4) | 0.0431 |
Loop diuretic, n (%) | 66 (29.3) | 72 (32.0) | 0.4511 |
Thiazide diuretic, n (%) | 35 (15.6) | 42 (18.7) | 0.3821 |
Glycoside, n (%) | 12 (5.3) | 14 (6.2) | 0.6251 |